David Schrenk - Feb 28, 2023 Form 3 Insider Report for EVERSPIN TECHNOLOGIES INC (MRAM)

Role: VP Sales and Business
Signature: /s/ Anthony Griff, Attorney-in-Fact
Stock symbol: MRAM
Transactions as of: Feb 28, 2023
Transactions value $: $0
Form type: 3
Date filed: 3/7/2023, 05:45 PM
Next filing: Mar 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MRAM	Common Stock						24.6K	Feb 28, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MRAM	Stock Option (Right to Buy)							Feb 28, 2023	Common Stock	2.11K	$8.52	Direct	F2
holding	MRAM	Stock Option (Right to Buy)							Feb 28, 2023	Common Stock	3.06K	$6.86	Direct	F3
holding	MRAM	Stock Option (Right to Buy)							Feb 28, 2023	Common Stock	7.29K	$2.23	Direct	F4
holding	MRAM	Stock Option (Right to Buy)							Feb 28, 2023	Common Stock	1.21K	$2.56	Direct	F5
holding	MRAM	Stock Option (Right to Buy)							Feb 28, 2023	Common Stock	12.5K	$5.62	Direct	F6
holding	MRAM	Stock Option (Right to Buy)							Feb 28, 2023	Common Stock	15K	$8.17	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 22,043 shares subject to unvested restricted stock units.
F2	Fully vested.
F3	The option vested as to 25% of the shares on August 26, 2020, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on August 26, 2023. The original grant was for 6,986 shares, of which 3,929 shares have been exercised.
F4	The option vested as to 25% of the shares on March 24, 2021, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on March 24, 2024. The original grant was for 12,500 shares, of which 5,208 shares have been exercised.
F5	The option vested as to 25% of the shares on April 7, 2021, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on April 7, 2024. The original grant was for 2,000 shares, of which 791 shares have been exercised.
F6	The option vested as to 25% of the shares on March 10, 2022, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on March 10, 2025.
F7	The option vested as to 25% of the shares on February 28, 2023, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on February 28, 2026.